Table 1. Characteristics of the 411 patients included in the study.
| N | % | |
|---|---|---|
| Sex | ||
| Female | 192 | 47.2 |
| Male | 215 | 52.1 |
| HT | ||
| Yes | 209 | 50.9 |
| No | 202 | 49.1 |
| Diabetes Mellitus | ||
| Yes | 66 | 83.5 |
| No | 345 | 16.0 |
| Pathologic state | ||
| Yes | 281 | 31.5 |
| No | 130 | 68.0 |
| Target organ damage | ||
| Yes | 191 | 46.2 |
| No | 220 | 53.3 |
| Altered basal glycaemia | ||
| Yes | 51 | 12.3 |
| No | 360 | 87.2 |
| BMI | ||
| BMI < 25 | 74 | 17.9 |
| BMI 25–30 | 210 | 50.8 |
| BMI > 30 | 127 | 30.8 |
| Dyslipidemia | ||
| Yes | 386 | 93.5 |
| No | 24 | 5.8 |
| Elevated PP | ||
| Yes | 97 | 23.5 |
| No | 314 | 76.0 |
| LVH | ||
| Yes | 34 | 8.2 |
| No | 367 | 88.9 |
| C-IMT | ||
| Yes | 73 | 17.7 |
| No | 336 | 81.4 |
| Altered PWV | ||
| Yes | 63 | 15.3 |
| No | 343 | 83.1 |
| PAD | ||
| Yes | 7 | 1.7 |
| No | 402 | 98.3 |
| CV risk | ||
| <1% | 58 | 14.1 |
| 1–5% | 198 | 48.2 |
| 5–10% | 84 | 20.4 |
| >10% | 71 | 17.3 |
| Antihypertensive drugs | ||
| Yes | 227 | 55.0 |
| No | 184 | 44.6 |
| Antidiabetic drugs | ||
| Yes | 66 | 16.0 |
| No | 345 | 83.5 |
| Lipid-lowering drugs | ||
| Yes | 164 | 39.7 |
| No | 247 | 59.8 |
BMI: body mass index; C-IMT: carotid intima media thickness; CV: cardiovascular; HT: hypertension; LVH: left ventricular hypertrophy; PAD: peripheral arterial disease; PP: pulse pressure; PWV: pulse wave velocity.